Terms: = Thyroid cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
66 results:
1. Columnar Cell thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
2. Epigenetic inhibition of CTCF by hn1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract] [Full Text] [Related]
3. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
4. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract] [Full Text] [Related]
5. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
Zhang R; Dong M; Tu J; Li F; Deng Q; Xu J; He X; Ding J; Xia J; Sheng D; Chang Z; Ma W; Dong H; Zhang Y; Zhang L; Zhang L; Liu S
Signal Transduct Target Ther; 2023 Mar; 8(1):97. PubMed ID: 36859354
[TBL] [Abstract] [Full Text] [Related]
6. thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
8. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
9. Blocking CDK7-Mediated notch1-cMYC Signaling Attenuates cancer Stem Cell Activity in Anaplastic thyroid cancer.
Doolittle WKL; Zhao L; Cheng SY
Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
[No Abstract] [Full Text] [Related]
10. Reconstruction and Exploratory Analysis of mTORC1 Signaling Pathway and Its Applications to Various Diseases Using Network-Based Approach.
Buddham R; Chauhan S; Narad P; Mathur P
J Microbiol Biotechnol; 2022 Mar; 32(3):365-377. PubMed ID: 35001007
[TBL] [Abstract] [Full Text] [Related]
11. The Knockdown of Nrf2 Suppressed Tumor Growth and Increased the Sensitivity to Lenvatinib in Anaplastic thyroid cancer.
Gong Z; Xue L; Wei M; Liu Z; Vlantis AC; van Hasselt CA; Chan JYK; Li D; Zeng X; Tong MCF; Chen GG
Oxid Med Cell Longev; 2021; 2021():3900330. PubMed ID: 34527171
[TBL] [Abstract] [Full Text] [Related]
12. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway.
Xu J; Xu W; Yang X; Liu Z; Sun Q
Aging (Albany NY); 2021 Jun; 13(12):16471-16484. PubMed ID: 34230221
[TBL] [Abstract] [Full Text] [Related]
13. INI1-Deficient thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract] [Full Text] [Related]
14. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN.
Zhang YQ; Liang YK; Wu Y; Chen M; Chen WL; Li RH; Zeng YZ; Huang WH; Wu JD; Zeng D; Gao WL; Chen CF; Lin HY; Yang RQ; Zhu JW; Liu WL; Bai JW; Wei M; Wei XL; Zhang GJ
Cell Death Dis; 2021 May; 12(6):502. PubMed ID: 34006834
[TBL] [Abstract] [Full Text] [Related]
15. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
[TBL] [Abstract] [Full Text] [Related]
16. hn1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1.
Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M
Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451
[TBL] [Abstract] [Full Text] [Related]
17. Aberrant expression of semaphorin 6B affects cell phenotypes in thyroid carcinoma by activating the Notch signalling pathway.
Lv XJ; Chen X; Wang Y; Yu S; Pang L; Huang C
Endokrynol Pol; 2021; 72(1):29-36. PubMed ID: 33125690
[TBL] [Abstract] [Full Text] [Related]
18. BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating notch1 signaling in breast cancer.
Chen J; Lai YH; Ooi S; Song Y; Li L; Liu TY
Breast Cancer Res Treat; 2020 Nov; 184(2):287-300. PubMed ID: 32772271
[TBL] [Abstract] [Full Text] [Related]
19. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
[TBL] [Abstract] [Full Text] [Related]
20. The role of microRNA in cisplatin resistance or sensitivity.
Wang S; Li MY; Liu Y; Vlantis AC; Chan JY; Xue L; Hu BG; Yang S; Chen MX; Zhou S; Guo W; Zeng X; Qiu S; van Hasselt CA; Tong MC; Chen GG
Expert Opin Ther Targets; 2020 Sep; 24(9):885-897. PubMed ID: 32559147
[TBL] [Abstract] [Full Text] [Related]
[Next]
